New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.
Start-Up Raises $200 Million to Speed Up Drug Trials
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.
Written by
in